Pancreatic cancer

Drug delivery of targeted therapies for pancreatic cancer, motor neurone disease

Associate Professor Kara Vine-Perrow is a cancer researcher, educator and research leader in the Faculty of Science, Medicine & Health at the University of Wollongong, where she serves as Deputy Director (Community Partnership and Impact) of the Molecular Horizons Research Institute and leads the Targeted Cancer Therapeutics Laboratory. Her research focuses on developing innovative drug delivery technologies, implantable medical devices and RNA-based therapeutics for difficult-to-treat diseases, with a particular emphasis on pancreatic cancer and motor neurone disease.

Novel therapy for pancreatic cancers, targeting molecular foundation

Dr Michael Lee is an experienced medical oncologist, sub-specialising in gastrointestinal cancers and neuroendocrine tumours at the Peter MacCallum Cancer Centre.

He plays a key role in molecular tumour boards at VCCC Alliance (Victorian Comprehensive Cancer Centre) and MPCCC (Monash Partners Comprehensive Cancer Consortium), ensuring the accurate and effective use of precision medicine in cancer care across the state.

Scroll to top